700 related articles for article (PubMed ID: 16352628)
1. Peptide-induced immune protection of CD8+ T cell-deficient mice against Friend retrovirus-induced disease.
Kawabata H; Niwa A; Tsuji-Kawahara S; Uenishi H; Iwanami N; Matsukuma H; Abe H; Tabata N; Matsumura H; Miyazawa M
Int Immunol; 2006 Jan; 18(1):183-98. PubMed ID: 16352628
[TBL] [Abstract][Full Text] [Related]
2. Identification of a protective CD4+ T-cell epitope in p15gag of Friend murine leukemia virus and role of the MA protein targeting the plasma membrane in immunogenicity.
Sugahara D; Tsuji-Kawahara S; Miyazawa M
J Virol; 2004 Jun; 78(12):6322-34. PubMed ID: 15163726
[TBL] [Abstract][Full Text] [Related]
3. Role of natural killer cells in resistance against friend retrovirus-induced leukemia.
Iwanami N; Niwa A; Yasutomi Y; Tabata N; Miyazawa M
J Virol; 2001 Apr; 75(7):3152-63. PubMed ID: 11238842
[TBL] [Abstract][Full Text] [Related]
4. Essential role for virus-neutralizing antibodies in sterilizing immunity against Friend retrovirus infection.
Messer RJ; Dittmer U; Peterson KE; Hasenkrug KJ
Proc Natl Acad Sci U S A; 2004 Aug; 101(33):12260-5. PubMed ID: 15297622
[TBL] [Abstract][Full Text] [Related]
5. Immunization with a single T helper cell epitope abrogates Friend virus-induced early erythroid proliferation and prevents late leukemia development.
Miyazawa M; Fujisawa R; Ishihara C; Takei YA; Shimizu T; Uenishi H; Yamagishi H; Kuribayashi K
J Immunol; 1995 Jul; 155(2):748-58. PubMed ID: 7541823
[TBL] [Abstract][Full Text] [Related]
6. Different immunological requirements for protection against acute versus persistent Friend retrovirus infections.
Dittmer U; Hasenkrug KJ
Virology; 2000 Jun; 272(1):177-82. PubMed ID: 10873760
[TBL] [Abstract][Full Text] [Related]
7. Protection of mice against Friend retrovirus infection by vaccination with antigen-loaded, spleen-derived dendritic cells.
Reuter T; Heldmann M; Schimmer S; Schepers K; Dittmer U
Vaccine; 2004 Jul; 22(21-22):2686-9. PubMed ID: 15246598
[TBL] [Abstract][Full Text] [Related]
8. Role of interleukin-4 (IL-4), IL-12, and gamma interferon in primary and vaccine-primed immune responses to Friend retrovirus infection.
Dittmer U; Peterson KE; Messer R; Stromnes IM; Race B; Hasenkrug KJ
J Virol; 2001 Jan; 75(2):654-60. PubMed ID: 11134279
[TBL] [Abstract][Full Text] [Related]
9. Kinetics of CD8+ effector T cell responses and induced CD4+ regulatory T cell responses during Friend retrovirus infection.
Zelinskyy G; Kraft AR; Schimmer S; Arndt T; Dittmer U
Eur J Immunol; 2006 Oct; 36(10):2658-70. PubMed ID: 16981182
[TBL] [Abstract][Full Text] [Related]
10. Host genetic factors that control immune responses to retrovirus infections.
Miyazawa M; Tsuji-Kawahara S; Kanari Y
Vaccine; 2008 Jun; 26(24):2981-96. PubMed ID: 18255203
[TBL] [Abstract][Full Text] [Related]
11. Immunoprotective determinants in friend murine leukemia virus envelope protein.
Hasenkrug KJ; Brooks DM; Robertson MN; Srinivas RV; Chesebro B
Virology; 1998 Aug; 248(1):66-73. PubMed ID: 9705256
[TBL] [Abstract][Full Text] [Related]
12. The role of CD4 and CD8 T cells in recovery and protection from retroviral infection: lessons from the Friend virus model.
Hasenkrug KJ; Dittmer U
Virology; 2000 Jul; 272(2):244-9. PubMed ID: 10873767
[No Abstract] [Full Text] [Related]
13. Flow-microfluorometric monitoring of oligoclonal CD8+ T cell responses to an immunodominant Moloney leukemia virus-encoded epitope in vivo.
Brawand P; Biasi G; Horvath C; Cerottini JC; MacDonald HR
J Immunol; 1998 Feb; 160(4):1659-65. PubMed ID: 9469422
[TBL] [Abstract][Full Text] [Related]
14. Restriction of Friend virus-induced erythroid cell proliferation by CD4+ T-lymphocytes that recognize a single gp70 epitope.
Miyazawa M; Fujisawa R
Leukemia; 1997 Apr; 11 Suppl 3():227-9. PubMed ID: 9209349
[TBL] [Abstract][Full Text] [Related]
15. Contributions of antibody and T cell subsets to protection elicited by immunization with a replication-defective mutant of herpes simplex virus type 1.
Morrison LA; Knipe DM
Virology; 1997 Dec; 239(2):315-26. PubMed ID: 9434723
[TBL] [Abstract][Full Text] [Related]
16. Neonate-primed CD8+ memory cells rival adult-primed memory cells in antigen-driven expansion and anti-viral protection.
Fadel SA; Cowell LG; Cao S; Ozaki DA; Kepler TB; Steeber DA; Sarzotti M
Int Immunol; 2006 Feb; 18(2):249-57. PubMed ID: 16418189
[TBL] [Abstract][Full Text] [Related]
17. Immunization with a murine cytomegalovirus based vector encoding retrovirus envelope confers strong protection from Friend retrovirus challenge infection.
Bongard N; Le-Trilling VTK; Malyshkina A; Rückborn M; Wohlgemuth K; Wensing I; Windmann S; Dittmer U; Trilling M; Bayer W
PLoS Pathog; 2019 Sep; 15(9):e1008043. PubMed ID: 31568492
[TBL] [Abstract][Full Text] [Related]
18. Use of adoptive transfer and Winn assay procedures in the further analysis of antiviral acquired immunity in mice protected against Friend leukemia virus-induced disease by passive serum therapy.
Genovesi EV; Pettey CL; Collins JJ
Cancer Res; 1984 Apr; 44(4):1489-98. PubMed ID: 6608407
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the Friend Virus model for the development of improved adenovirus-vectored anti-retroviral vaccination strategies.
Bayer W; Schimmer S; Hoffmann D; Dittmer U; Wildner O
Vaccine; 2008 Jan; 26(5):716-26. PubMed ID: 18160188
[TBL] [Abstract][Full Text] [Related]
20. DNA vaccines expressing B and T cell epitopes can protect mice from FMDV infection in the absence of specific humoral responses.
Borrego B; Fernandez-Pacheco P; Ganges L; Domenech N; Fernandez-Borges N; Sobrino F; Rodríguez F
Vaccine; 2006 May; 24(18):3889-99. PubMed ID: 16563575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
